Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4863079, 14 pages
https://doi.org/10.1155/2017/4863079
Review Article

Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research

1Department of Anesthesiology, Loma Linda University Medical Center, Loma Linda, CA 92354, USA
2Department of Physiology and Pharmacology, Loma Linda University School of Medicine, 11041 Campus Street, Risley Hall, Room 219, Loma Linda, CA 92354, USA
3Department of Neurosurgery, University Hospital Innsbruck, 6020 Tyrol, Austria
4Department of Neurosurgery, Loma Linda University School of Medicine, Loma Linda, CA 92354, USA

Correspondence should be addressed to John H. Zhang; moc.oohay@0193gnahznhoj

Received 27 September 2016; Accepted 23 November 2016; Published 14 February 2017

Academic Editor: Nicola Simola

Copyright © 2017 Cesar Reis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Cesar Reis, Onat Akyol, Wing Mann Ho, et al., “Phase I and Phase II Therapies for Acute Ischemic Stroke: An Update on Currently Studied Drugs in Clinical Research,” BioMed Research International, vol. 2017, Article ID 4863079, 14 pages, 2017. https://doi.org/10.1155/2017/4863079.